AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2017.
نویسندگان
چکیده
a Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Schleswig-Holstein/Campus Lübeck, Lübeck, Germany; b Klinik für Gynäkologie und Geburtshilfe, Agaplesion Markus Krankenhaus, Frankfurt/M., Germany; c Klinik für Frauenheilkunde, Geburtshilfe und Reproduktionsmedizin, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany; d Klinik und Poliklinik für Gynäkologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany; e Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Ulm, Ulm, Germany; f Klinik und Poliklinik für Gebursthilfe und Frauengesundheit, Abteilung für Konservative und Molekulare Gynäkologische Onkologie, Universitätsklinikum Mainz, Mainz, Germany
منابع مشابه
AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2014.
For the last 13 years, the Breast Committee of the Arbeits gemeinschaft Gynäkologische Onkologie (German Gyneco logical Oncology Group, AGO) has issued annually updated evidencebased recommendations for the diagnosis and treat ment of patients with early and metastatic breast cancer. The AGO Breast Committee consists of 45 gynecological onco logists specialized in breast cancer and interdi...
متن کاملAGO Recommendations for Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2013.
for their scientific validity (Oxford Level of Evidence, LoE; www.cebm.net [1]) and clinical relevance (AGO Grades of Recommendation; table 1). All AGO Breast Committee members have declared their potential conflicts of interest. Here, we present the 2013 update of these guidelines focussing on changes made this year. The full version of the 2013 update is available online as a PDF file [2] in ...
متن کاملAGO Recommendations for Diagnosis and Treatment of Patients with Early and Metastatic Breast Cancer: Update 2012.
There were no clinically relevant changes in the AGO recommendations concerning breast cancer risk and prevention compared to 2011. On the other hand, there were some important publications stimulating further investigations. In 2010, RAD51C was identified as the 3rd high-risk gene for breast and ovarian cancer, which is, however, rarely mutated [124]. RAD51C constitutes a proof of concept for ...
متن کاملAGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2015.
Level of Evidence, LoE; www.cebm.net [1]) and ii) their clinical relevance (AGO grades of recommendation) (table 1). All AGO Breast Committee members have declared their potential conflicts of interest. Here, we present the 2015 update of these guidelines, focusing on relevant changes introduced this year. The full version of the updated 2015 slide set is available online as a PDF file [2] in E...
متن کاملAn unusual metastatic breast cancer presentation Report of a case
ABSTRACTWe are reporting a 43-year-old female breast cancer case with a solitary metastatic adenocarcinoma in clivus. This patient with a stage II (T1N1M0) breast cancer history has been followed for 7 years. Modified Radical Mastectomy (MRM) and 6 courses chemotherapy with CMF (Cyclophosphamide, Metotrexate, 5FU) regimen were done for her at the time of diagnosis. Also, she took tamoxifen tw...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Breast care
دوره 12 3 شماره
صفحات -
تاریخ انتشار 2017